Citadel Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.58M | Buy |
|
|||||
|
2025
Q2 | $6.65M | Sell |
|
|||||
|
2025
Q1 | $14M | Sell |
|
|||||
|
2024
Q4 | $18.5M | Buy |
|
|||||
|
2024
Q3 | $1.54M | Sell |
|
|||||
|
2024
Q2 | $5.59M | Buy |
|
|||||
|
2024
Q1 | $3.39M | Buy |
|
|||||
|
2023
Q4 | $360K | Sell |
|
|||||
|
2023
Q3 | $2.32M | Sell |
|
|||||
|
2023
Q2 | $5.51M | Buy |
|
|||||
|
2023
Q1 | $4.04M | Sell |
|
|||||
|
2022
Q4 | $5.95M | Buy |
|
|||||
|
2022
Q3 | $5.34M | Buy |
|
|||||
|
2022
Q2 | $2.5M | Sell |
|
|||||
|
2022
Q1 | $6.51M | Buy |
|
|||||
|
2021
Q4 | $3.42M | Buy |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2021
Q2 | – | Hold |
|